NDC 68727-800

DEFITELIO

Defibrotide Sodium

DEFITELIO is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Jazz Pharmaceuticals, Inc.. The primary component is Defibrotide Sodium.

Product ID68727-800_0173efe0-e4e2-41f6-b044-81f707120906
NDC68727-800
Product TypeHuman Prescription Drug
Proprietary NameDEFITELIO
Generic NameDefibrotide Sodium
Dosage FormInjection, Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2016-03-30
Marketing CategoryNDA / NDA
Application NumberNDA208114
Labeler NameJazz Pharmaceuticals, Inc.
Substance NameDEFIBROTIDE SODIUM
Active Ingredient Strength80 mg/mL
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 68727-800-01

2.5 mL in 1 VIAL (68727-800-01)
Marketing Start Date2016-03-30
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 68727-800-02 [68727080002]

DEFITELIO INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA208114
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2016-03-30

NDC 68727-800-01 [68727080001]

DEFITELIO INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA208114
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2016-03-30

Drug Details

Active Ingredients

IngredientStrength
DEFIBROTIDE SODIUM80 mg/mL

OpenFDA Data

SPL SET ID:2c3db989-d7ad-41ed-9ebf-698dcf6c24ec
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1746527
  • 1746532
  • UPC Code
  • 0368727800021

  • Trademark Results [DEFITELIO]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    DEFITELIO
    DEFITELIO
    87638258 5652544 Live/Registered
    Gentium S.r.l.
    2017-10-09
    DEFITELIO
    DEFITELIO
    87034509 5487126 Live/Registered
    Gentium S.r.l.
    2016-05-12
    DEFITELIO
    DEFITELIO
    79099301 4162914 Live/Registered
    Gentium S.r.l.
    2011-05-16

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.